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Recent evidence supports a role for RNA as a common pathogenic agent in both the ‘polyglutamine’ and
‘untranslated’ dominant expanded repeat disorders. One feature of all repeat sequences currently associated
with disease is their predicted ability to form a hairpin secondary structure at the RNA level. In order to inves-
tigate mechanisms by which hairpin-forming repeat RNAs could induce neurodegeneration, we have looked
for alterations in gene transcript levels as hallmarks of the cellular response to toxic hairpin repeat RNAs.
Three disease-associated repeat sequences—CAG, CUG and AUUCU—were speciﬁcally expressed in the
neurons of Drosophila and resultant common transcriptional changes assessed by microarray analyses.
Transcripts that encode several components of the Akt/Gsk3-b signalling pathway were altered as a conse-
quence of expression of these repeat RNAs, indicating that this pathway is a component of the neuronal
response to these pathogenic RNAs and may represent an important common therapeutic target in this
class of diseases.
INTRODUCTION
Despite the identiﬁcation of expanded repeat sequences as
disease-causing mutations two decades ago (1,2), the mechan-
isms by which this class of mutations exert their pathogenic
effect still remain unclear. Repeat expansions that cause domi-
nantly inherited diseases have been classiﬁed into two distinct
groups of diseases, based upon the location of the expanded
repeattractwithinthegene.Onegroupistheresultoftheexpan-
sion of trinucleotide repeat tracts within the coding regions of a
number of unrelated genes. The most common such expansion
is of a CAG repeat encoding glutamine, resulting in the ‘poly-
glutamine diseases’ which include Huntington’s disease (HD),
spinal bulbar muscular atrophy, dentatorubral-pallidoluysian
atrophy and spinocerebellar ataxia (SCA) types 1, 2, 3, 6, 7
and 17 (Fig. 1). The polyglutamine diseases do not appear to
be the result of a simple loss-of-function mechanism, since
they show dominant inheritance and share a number of clinical
features. This phenotypic overlap suggests that there are likely
to be pathogenic mechanisms involved which are not gene-
speciﬁc (3). There is a large amount of evidence to support a
role forthe polyglutamine peptidesthemselves inpathogenesis,
including the demonstrated intrinsic toxicity of polyglutamine
peptidesintransfectedcells(4–6)andDrosophilamodels(7,8).
There are another nine dominantly inherited expanded
repeat diseases that are caused by the expansion of repeat
tracts within the non-coding regions of genes (the ‘untrans-
lated repeat’ diseases, Fig. 1). To date, expansions of tri-,
tetra- and penta-nucleotide repeats of this class have been
identiﬁed as the mutations causing myotonic dystrophy
(DM) types 1 and 2 (DM1 and 2), HD like-2 (HDL-2),
fragile X tremor ataxia syndrome (FXTAS) and spinocerebel-
lar ataxia types 8, 10 and 12. Despite the apparent inability of
these expanded repeat sequences to code for polyglutamine, in
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polyglutamine diseases, suggesting that a common pathogenic
mechanism may play a role in both classes of disease. Further-
more, given that there are diseases caused by the expansion of
repeat sequences of differing sequence composition and that
the expansions reside in functionally distinct genes, it seems
likely that some common property of the expanded repeat
tracts may be a component of pathogenesis in both sets of
diseases.
One common property of disease-causing expanded repeat
sequences is the predicted ability of their RNA transcripts to
form strong hairpin secondary structures. In the case of CNG
repeats, this structure is formed through binding between C
and G residues, with a mismatch every third base (9,10). Tri-
nucleotide repeats of this type account for the majority of the
expanded repeat diseases, including all of the polyglutamine
diseases. Expanded CCTG repeats, the mutation responsible
for DM2, have been predicted to form a similar structure to
CUG repeats in vivo (9), while the penta-nucleotide AUUCU
repeat which is expanded in SCA10 is predicted to form an
unusual anti-parallel hairpin structure, with a C-C mismatch
everyﬁfthbaseandanequalratioofA-U/U-Umismatches(11).
A central role for hairpin RNA-mediated pathogenesis was
ﬁrst suggested in DM1 and 2. In both cases, the expanded
repeat tract binds and sequesters the splicing factor
muscleblind-like (MBNL) (12). Sequestration of MBNL is
thought to be pathogenic via both the loss of MBNL-splicing
activity and the associated mis-regulation of splicing by the
antagonistic splicing factor CUG-binding protein (CUG-BP),
since over-expression of human CUG-BP is sufﬁcient to reca-
pitulate a number of features of DM in a mouse model (13). A
number of MBNL-splicing targets, including chloride channel
1, troponin T type 3 and insulin receptor, are mis-spliced in
both DM1 and 2 individuals as a result of the inappropriate
interaction of the expanded repeat-containing RNA and
endogenous RNA-binding proteins (14,15).
A similar mechanism of pathogenesis has also been
suggested for FXTAS, which is caused by a CGG expansion
in the 5′UTR of the Fragile X mental retardation 1 (FMR1)
gene within the pre-mutation range (55–200 repeats) for
fragile X syndrome. Individuals with FXTAS also show
inclusions which contain MBNL along with several intermedi-
ate ﬁlament proteins, including lamins A/C and internexin, and
heterogeneous nuclear ribonucleoprotein A2 (hnRNP A2)
(16). In cells from SCA10 individuals and transgenic mice
ectopically expressing the expanded intronic AUUCU repeat
tract, inclusions containing both the expanded repeat RNA
and the RNA-binding protein hnRNP K have been identiﬁed.
The sequestration of hnRNP K within these aggregates is
suggested to result in an increase in translocation of PKCd
to the mitochondria, resulting in induction of apoptosis (17).
The localization of this repeat sequence with MBNL has not
been demonstrated to date.
Recent evidence also supports a role for RNA-mediated
pathogenesis in the polyglutamine diseases. In a Drosophila
model of SCA3 (18), altering expression levels of the
Drosophila muscleblind (Mbl) splicing factor was found to
modify phenotypes associated with expression of a pure CAG
repeat tract, but not a mixed CAG/CAA repeat. This result
suggests that an interaction between CAG repeats and Mbl is
occurring at the RNA level and that the secondary structure of
the RNA species is important for this interaction. Nevertheless,
bindingofMBNLtoexpandedCAGrepeatshasbeenshownnot
to elicit the same splicing defects as binding to CUG repeats in
transfected cells and therefore the biological outcome of this
interaction remains unclear (19). It does, however, suggest a
pathogenic role for expanded repeat-containing RNA in the
polyglutamine diseases. There is therefore mounting evidence
of a role for expanded repeat-containing RNA species in patho-
genesis of both the untranslated expanded repeat diseases and
the polyglutamine diseases.
Drosophila is well established as a model for polyglutamine
disease (7,20–22) and has also been demonstrated to exhibit
neurodegenerative phenotypes resulting from expression of
expanded repeat RNAs (18,23–25). In this study, we have
used a Drosophila model of expanded repeat pathogenesis to
investigate common transcriptional changes in neurons result-
ing from expression of different disease-associated RNA
repeat sequences with the aim of identifying common cellular
changes resulting from the intrinsic toxicity of repeat RNAs.
The repeat sequences investigated—CAG, CUG and
AUUCU—represent the mutations responsible for the majority
of the dominant expanded repeat diseases, including all of the
polyglutamine diseases as well as the untranslated repeat dis-
eases DM1, HDL-2, SCA8, 10 and 12.
There are several unique components to the analyses per-
formed in this study. First, it describes the only direct com-
parison of the transcriptional outcomes of expression of
CAG and CUG expanded repeat RNAs. Furthermore, it is
also the only study thus far to examine the general transcrip-
tional response to neuronal expression of CUG repeat RNA.
Since neuronal toxicity resulting from CUG repeat expansion
is a feature of DM1 and may also play a role in HDL-2, deﬁn-
ing the pathways involved in CUG repeat-mediated neuronal
toxicity is of great importance. Similarly, while toxicity of
CAG repeat RNA has now been described in several model
systems (18,26,27), the cellular basis of this toxicity has not
yet been extensively explored. Additionally, this is also the
ﬁrst report of the effects of expression of the
SCA10-associated expansion in a Drosophila model.
Figure 1. Schematic representation of the mutations currently known to cause
dominant expanded repeat diseases. Expansions can occur either within the
coding region of the gene, such as the CAG repeat expansions resulting in
the ‘polyglutamine’ diseases (above), or within non-coding regions, resulting
in the ‘untranslated’ repeat diseases (below). Expansions of tri-, tetra- and
penta-nucleotide repeat sequences have been identiﬁed as pathogenic
mutations in these diseases. While SCA8 has typically been considered an
‘untranslated’ repeat disease, polyglutamine aggregates have also been
detected in both a mouse model and human autopsy tissue (51). DM, myotonic
dystrophy; DRPLA, dentatorubral-pallidoluysian atrophy; FXTAS, fragile X
tremor ataxia syndrome; HD, Huntington’s disease; HDL-2, Huntington’s
disease like-2; SBMA, spinal bulbar muscular atrophy; SCA, spinocerebellar
ataxia.
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We have previously reported a Drosophila expanded repeat
disease model utilizing the UAS-GAL4 system to drive
expression of different expanded repeat sequences in a tissue-
speciﬁc manner (8). In this model, repeats are expressed in the
context of a short peptide sequence (7) which is unrelated to
the context in any of the expanded repeat diseases (Fig. 2A).
In contrast to most other models described in the literature,
this model therefore allows investigation of the intrinsic tox-
icity of expanded repeat sequences, which is likely to
account for common features observed in these diseases.
ThisDrosophilamodelwaspreviouslyusedtoinvestigatethe
contribution of hairpin-forming RNA to toxicity of polygluta-
mine tracts (8) by comparing the phenotypes seen when CAG
repeats, which encode polyglutamine and are able to form an
RNA hairpin secondary structure, or CAA repeats, which
encode polyglutamine but are unstructured at the RNA level,
are expressed in the Drosophila eye. The results obtained in
this investigation suggested that the majority of the phenotype
seen in ﬂies expressing polyglutamine is likely to be the result
ofthepolyglutaminepeptideitselfandnottherepeat-containing
RNA. However, subtle cellular changes resulting from
expression of RNA species, which may result in cell death
over an extended period of time, were not further investigated
(Fig. 2K). In this study, we look speciﬁcally at cellular
changes resulting from neuronal expression of disease-causing
untranslated expanded repeat sequences.
Expression of expanded, untranslated CAG, CAA, CUG
and AUUCU repeat RNAs in Drosophila
In order to investigate the intrinsic toxicity of different
disease-associated expanded repeat RNA sequences, a set of
constructs were generated in which a termination codon is
inserted ahead of the repeat sequence such that the repeat
tract is effectively shifted into the 3′UTR of the transcript in
each case (Fig. 2F). Expression of this construct containing
a hairpin-forming CAG repeat RNA (rCAG) does not result
in a phenotype when expressed in the Drosophila eye, as pre-
viously reported (8). Similarly, expression of untranslated
hairpin-forming CUG repeat RNA (rCUG) or unstructured
CAA repeat RNA (rCAA) does not alter the appearance of
the Drosophila eye.
An identical construct was also generated with an insertion
of 65 interrupted repeats of the penta-nucleotide AUUCU
sequence responsible for the rare spinocerebellar ataxia,
SCA10. The sequence of the repeat tract in this construct is
(ATTCT)20 ACTCT (ATTCT)23 ATTCC (ATTCT)15
ATTTT (ATTCT)7, surrounded by 141 bp of sequence from
the region of intron 9 of human ataxin-10. Although the
repeat number in this construct is lower than in the CAG,
CUG and CAA repeat constructs, in each case the total size
of the repeat tract is  300 bp and therefore, in the cases
where a secondary structure is predicted, the resulting
hairpin RNAs will be of similar size.
In order to increase the expression level of expanded repeat
RNA, Drosophila lines carrying four independent insertions of
each of these repeat constructs were subsequently generated.
Expression of four independent insertions of untranslated
CAG, CUG, CAA or AUUCU repeat RNAs in the Drosophila
eye does not result in any external phenotype (Fig. 2G–J).
This is in contrast to the phenotypes observed when a single
Figure 2. Schematic representation of repeat constructs and effect of
expression of translated and untranslated expanded repeat constructs on the
external appearance of the Drosophila eye. (A) Translated repeat constructs:
similarly sized expanded repeat tracts are inserted downstream of UAS sites
to allow expression under the control of a GAL4 driver. The repeats are
ﬂanked by six amino acids on the N-terminal side and four on the C-terminal,
and a myc/ﬂag epitope tag is located downstream. Repeat sequences are CAA
and CAG, both of which encode polyglutamine, and CUG which encodes
polyleucine. CAG and CUG repeat RNAs are predicted to form a hairpin sec-
ondary structure, while the CAA repeat RNA is not. (B) Expression of UAS
sequences alone results in an eye of wild-type appearance. (C and D)
Expression of polyglutamine encoded by either a CAG or CAA repeat tract
results in an indistinguishable loss of pigment phenotype in the Drosophila
eye (8). (E) Expression of polyleucine encoded by a CUG repeat tract
results in a mild disruption to the patterning of the eye. (F) Untranslated
repeat constructs: constructs in which the repeat tract is not translated were
generated by insertion of a stop codon upstream of the repeat tract. (G–J)
Expression of four transgene insertions of any of the untranslated expanded
repeat sequences does not cause a visible disruption to the external patterning
of the Drosophila eye. (K) Proposed mechanism of RNA-mediated pathogen-
esis in the expanded repeat diseases. Expression of expanded, untranslated
CAG, CUG or AUUCU repeat-containing RNAs, all of which are predicted
to form a hairpin secondary structure, results in cellular dysfunction which,
over an extended period of time, leads to apoptosis and neurodegeneration.
The expanded rCAA repeat RNA used in this study is not able to form a
hairpin secondary structure and therefore should not induce cellular dysfunc-
tion in this manner.
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both of which encode polyglutamine, or a translated CUG
repeat tract, encoding polyleucine, are expressed in the Droso-
phila eye (Fig. 2B–E). Similarly, no obvious defects were
observed in newly eclosed ﬂies when any of the untranslated
repeat RNA constructs were expressed pan-neuronally.
Detection of neuronal transcriptional changes resulting
from expression of expanded repeat RNA
While no phenotype was observed when rCAG, rCUG or
rAUUCU repeat RNAs were expressed in the nervous system
of newly eclosed ﬂies, the presence of expanded repeat tran-
scripts was detected in all cases (Supplementary Material,
Fig. S1A and C). To investigate the transcriptional effects of
expression of different expanded repeat sequences in the
neurons of Drosophila, microarray analyses were performed
using Affymetrix Drosophila Genome 2.0 arrays. A summary
of lines used in this analysis can be found in Supplementary
Material, Figure S1 and a summary of analyses performed can
be found in Figure 3A and B. For ﬂies expressing rCUG and
rCAG repeat sequences, separate microarray experiments
were performed using two alternative elav-GAL4 driver lines
(depicted in Supplementary Material, Fig. S1B) in order to
increase the robustness of these analyses. Multiple independent
lines carrying either two (experiment 1) or four (experiment 2)
transgene insertions of the repeat constructs were also tested, in
ordertominimizeanytranscriptionaleffectsrelatedtotheinser-
tion sites or expression levels of the transgenes. A single
four-transgene-insertion line was also included in experiment
2 for the rAUUCU repeat RNA.
For ﬂies expressing each hairpin repeat sequence, transcript
ratios were calculated compared with ﬂies expressing rCAA
repeat RNA, which cannot form a hairpin secondary structure,
as well as to ﬂies heterozygous for the elav-GAL4 driver, but
not expressing any repeat construct. Flies heterozygous for
elav-GAL4 were used as a control for genetic background.
However, since GAL4 has been reported to be toxic in
Drosophila neurons (28), ﬂies expressing rCAA repeat RNA
were included as an additional control. These ﬂies carry the
same number of transgene insertions as the rCAG, rCUG and
rAUUCU repeat expressing ﬂies, thus minimizing the contri-
bution of GAL4 toxicity to the transcriptional read-out. The
inclusion of ﬂies carrying elav-GAL4 alone should also identify
any effects resulting from expression of CAA repeat RNA,
which are therefore not the result of secondary structure of the
RNA species.
Some variation in expression levels of expanded repeat
sequences was observed, both between independent lines for
the same repeat and different repeat sequences. The most strik-
ing difference was seen in ﬂies expressing the rCAA repeat,
which showed consistently low steady-state levels compared
with other repeat sequences, possibly as a result of the inability
of this sequence to form a stable secondary structure. These
lines were included in analysis primarily as a control for
GAL4 toxicity. Additionally, with the exception of the
rAUUCU repeat, several independent lines were analysed for
each repeat sequence so as to minimize the impact of variation
in repeat expression levels on the transcriptional outcome.
In this way, candidate genes were identiﬁed which were sig-
niﬁcantly altered (two-tailed t-test value of P , 0.05) in ﬂies
expressing rCAG and rCUG expanded repeat sequences com-
pared with either ﬂies carrying elav-GAL4 alone or expressing
rCAA repeat RNA for each experiment. The total number of
genes identiﬁed in each comparison is shown in
Figure 3C. Genes found to be signiﬁcantly altered in more
than one comparison are also listed in Supplementary
Material, Table S1, while select candidates identiﬁed in both
experiments 1 and 2 are shown in Figure 3D. In experiment
2, a remarkably high overlap in transcriptional changes
between ﬂies expressing rCAG or rCUG repeats and those
expressing rAUUCU repeats was observed (between 40.7
and 71.4%, Fig. 3E), suggesting that there is a considerable
common component to cellular perturbation in ﬂies expressing
each of these repeat sequences. Select candidates identiﬁed in
experiment 2, which included the rAUUCU repeat expressing
ﬂies, are also listed in Figure 3F.
Genetic validation of effects of expanded repeat expression
Disruptions to the ordered patterning of ommatidia in the
Drosophila eye can be readily observed in adult ﬂies and for
this reason have been frequently used as a basis for genetic
screens. This approach has also been successfully used to
identify mechanisms of toxicity in models of expanded
repeat disease (24,29–33). We have tested candidate genes
identiﬁed by microarray analysis for their ability to alter the
patterning of the Drosophila eye. While expression of untrans-
lated expanded repeat RNAs does not result in a phenotype in
the eye (Fig. 2G–J), expression of expanded repeats encoding
polyglutamine or polyleucine causes an easily visualized per-
turbation to the exterior patterning of the eye (Fig. 2B–E) and
therefore these phenotypes were initially used as a screening
tool. Flies expressing a translated CAG repeat tract express
both polyglutamine peptide and hairpin-forming RNA, while
ﬂies expressing a translated CAA repeat express polygluta-
mine peptide in the absence of any hairpin-forming RNA.
Similarly, ﬂies expressing the translated CUG repeat construct
express both polyleucine peptide and hairpin-forming RNA.
Therefore, the ability of candidate genes to alter either the
polyglutamine or polyleucine phenotype in a manner that
was dependent upon the sequence composition of their encod-
ing RNAs would be indicative of this functional interaction
occurring at the RNA level. A similar methodology has been
used recently to identify Drosophila mblA as important in
pathogenesis in a model of SCA3 (18). In this study, the
authors demonstrate the ability of mblA to modify phenotypes
in ﬂies expressing truncated Ataxin-3 containing a pure CAG
repeat but not a mixed CAG/CAA repeat, suggesting that this
interaction is occurring at the RNA level.
Using this approach, two genes which were able to induce
toxicity in ﬂies expressing untranslated expanded repeats
were identiﬁed (Fig. 4). One of these genes, mef2, showed a
signiﬁcant interaction with translated CUG repeats, but
no interaction with translated CAG or CAA repeats
(Fig. 4D–F). This may suggest that Mef2 is a unique modiﬁer
of either polyleucine or CUG repeat RNA pathogenesis (or
both), or that a critical pathogenic threshold was not reached
in the ﬂies expressing expanded CAG repeats. The other
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lated CAG and CUG repeats (Fig. 4G and I). In ﬂies expres-
sing polyglutamine encoded by expanded CAG, reduction in
expression of mod(mdg4) by RNAi resulted in nearly com-
plete lethality, with the small number of ﬂies that did eclose
showing a signiﬁcant enhancement of the eye phenotype com-
pared with ﬂies expressing the CAG repeat alone (Fig. 4G). In
contrast, ﬂies expressing polyglutamine encoded by expanded
CAA with reduction in levels of mod(mdg4) showed only a
mild enhancement of the loss of pigment eye phenotype
(Fig. 4H). It is likely that the observed lethality in ﬂies expres-
sing CAG repeats with reduced mod(mdg4) is the result of the
expression of both the expanded repeat and the mod(mdg4)
RNAi construct in tissues other than the eye, as has been pre-
viously reported for the GMR-GAL4 driver (7).
Different RNA repeat sequences demonstrate distinct
interactions with candidate genes in our Drosophila model
While expression of rCAG, rCUG or rAUUCU repeats in the
Drosophila eye does not result in a phenotype, reducing
Figure 3. Experimental design of microarray experiments. (A) Experiment 1: microarray analyses were performed on ﬂies expressing two insertions of the
rCAG, rCUG and rCAA repeat sequences driven by the pan-neuronal elav
c155 –GAL4 driver and ﬂies heterozygous for the elav
c155 –GAL4 driver
(elav.+). For each repeat sequence, three lines with independent insertion sites were tested and candidates were selected which showed altered transcription
in all three lines. Microarray analysis of elav
c155 –GAL4 heterozygotes was performed in duplicate. Comparisons were performed between elav.rCAG or elav.
rCUG and each of the controls, which were elav.+ and elav.rCAA. (B) Experiment 2: microarray analysis was performed on ﬂies expressing four insertions
of the rCAG, rCUG, rCAA and rAUUCU repeat sequences driven by the pan-neuronal elavII–GAL4 driver and ﬂies heterozygous for the elavII–GAL4 driver
(elav.+). For rCUG, rCAG and rCAA, two lines with independent insertion sites were tested. A single four-transgene-insertion rAUUCU line was tested.
Microarray analysis of elavII –GAL4 heterozygotes was performed in duplicate. Comparisons were performed between elav.rCAG, elav.rCUG or elav.
rAUUCU and each of the controls, which were elav.+ and elav.rCAA. (C) Number of transcripts signiﬁcantly altered in ﬂies expressing rCAG and
rCUG repeats compared with ﬂies expressing rCAA repeats or heterozygous for the driver line. In each case, transcripts were selected which met the criteria:
log2(ratio).0.5 or ,20.5, where the ratio was calculated using an average of all independent lines tested, with a two-tailed t-test value of P , 0.05. Transcripts
common to more than one comparison are listed in Supplementary Material, Table S1. (D) Select genes which were detected as altered in ﬂies expressing rCAG
or rCUG in both microarray experiments. (E) Percent of genes altered in experiment 2 for rCAG and rCUG repeat expressing ﬂies which were also altered in ﬂies
expressing the rAUUCU repeat construct. These transcripts are listed in Supplementary Material, Table S2. (F) Number of transcripts signiﬁcantly altered in
experiment 2, selected for log2(ratio).0.5 or ,20.5, where the ratio was calculated using an average of all independent lines tested, with a two-tailed
t-test value of P , 0.05 for ﬂies expressing rCAG or rCUG. T-tests were not performed for rAUUCU repeat expressing ﬂies, since a single
four-transgene-insertion line was available for this repeat. Genes of particular interest are listed.
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ways involved in RNA-mediated toxicity may result in the
appearance of a phenotype, through pushing cells beyond a
critical pathogenic threshold. Therefore, candidates identiﬁed
by microarray analysis were also directly assayed for func-
tional interaction at the RNA level with untranslated expanded
repeat RNAs.
Co-expression of RNAi constructs targeting mef2 or
mod(mdg4) with expanded rCUG repeats in the Drosophila
eye resulted in a marked disruption of the pigmentation and
patterning of the eye (Fig. 4R and W) supporting a role for
these candidates in CUG repeat pathogenesis. No disruption
to the eye was observed when these RNAi constructs were
co-expressed with any other repeat sequence, supporting the
conclusion that these candidates may either be unique to
CUG repeat pathogenesis in this model, or that a critical
threshold of toxicity has not been reached in ﬂies expressing
the other expanded repeat sequences.
Common perturbation of downstream effectors of
Akt/Sgg signalling
A number of candidate genes identiﬁed in these microarray
analyses of different disease-associated expanded repeat
sequences were downstream effectors or regulators of the
Drosophila Gsk-3b (Sgg) signalling pathway (Fig. 5). There-
fore, we also investigated a role for this pathway in RNA-
mediated pathogenesis. Investigation of genetic interaction
between expanded translated repeat sequences revealed a reci-
procal effect of over-expressing or reducing Sgg expression in
ﬂies expressing translated CUG repeats (Fig. 6C, G, K). The
effect was less clear for CAG and CAA repeat-encoded poly-
glutamine expressing ﬂies. While there was a clear enhance-
ment when Sgg was over-expressed with either CAG or
CAA (Fig. 6A, B, I, J), there was little effect in either case
when Sgg expression levels were reduced (Fig. 6A, B, E, F).
Furthermore, no difference in the strength of interaction with
Sgg was observed between ﬂies expressing CAG or CAA,
and therefore it was not possible to determine whether there
was any contribution of the hairpin-forming repeat RNA to
this interaction.
To further investigate a role for this pathway in RNA-
mediated pathogenesis, we over-expressed Sgg in the presence
of each of the different untranslated repeat sequences. Over-
expression of Sgg in the presence of rCAG, rAUUCU or
rCAA expanded repeat sequences resulted in a decrease in
the amount of pigmentation in the eye compared with over-
expression of Sgg in ﬂies carrying four transgene insertions
in the absence of a repeat sequence (Fig. 6R–U compared
with Q). However, there was a marked increase in the
degree of roughness of the surface of the eye in ﬂies expres-
sing the rCAG or rAUUCU repeat sequences compared with
those expressing the rCAA repeat (Fig. 6R and U compared
with S). Since the steady-state levels of rCAA RNA are
Figure 4. Altering levels of Mef2 and Mod(mdg4) can modify the effect of expression of expanded repeat RNAs in the Drosophila eye. (A–C) Eye phenotypes
resulting from expression of expanded translated CAG, CAA and CUG repeats, as shown in Figure 2.( D and E) Co-expression of an RNAi construct targeting
mef2 with polyglutamine encoded by either a CAG or CAA repeat tract does not alter the appearance of the eye. (F) Reducing expression of mef2 in the eye of
ﬂies expressing a translated CUG repeat causes an enhancement of the polyleucine eye phenotype, resulting in ﬂies with smaller eyes which have a glazed
appearance and necrotic patches. (G) Reducing expression of mod(mdg4) in ﬂies expressing polyglutamine encoded by a CAG repeat results in an enhancement
of the eye phenotype and a reduction in viability of the ﬂies. (H) Expression of this same RNAi construct with polyglutamine encoded by a CAA repeat results in
a milder enhancement of the loss of pigment phenotype and no reduction in viability. (I) An enhancement of the polyleucine phenotype was also observed with
this RNAi construct. (J–N) Expression of four insertions of any of the untranslated repeat constructs alone does not cause an alteration to the appearance of the
Drosophila eye, as described in Figure 2; however co-expression of either the RNAi construct targeting mef2 or mod(mdg4) with four insertions of the rCUG
repeat construct was able to induce a strong eye phenotype (R and W). This effect was not seen with any of the other untranslated repeat constructs (O–Q, S,
T–V, X).
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Material, Fig. S1), it is not possible to determine whether
there is generally a stronger interaction between Sgg and
hairpin-forming RNA repeats. However, there does appear to
be a degree of sequence-dependence to the interaction with
Sgg, since the rAUUCU repeat RNA is expressed at similar
levels to rCUG, while the rCAG repeat RNA is expressed at
much higher levels than rCUG and yet there is a weaker inter-
action observed with Sgg in both cases. Co-expression of
rCUG repeat RNA with Sgg was completely lethal at 258C.
When ﬂies were grown at 238C to reduce expression levels
of the UAS constructs, a severe phenotype involving loss of
pigment, necrotic patches and a loss of ommatidial organiz-
ation of the eye was observed, indicating a strong interaction
between this repeat sequence and Sgg (Fig. 6T). Therefore,
while there appears to be a mild interaction between all
Figure 5. Alteration to activity of the Akt/GSK3-b signalling pathway can
explain a number of the changes observed in microarray analysis of ﬂies
expressing rCAG, rCUG and rAUUCU repeats in the nervous system.
Genes for which a Drosophila orthologue showed altered transcript levels in
microarray analysis of ﬂies expressing at least one of the untranslated repeat
constructs are shown in red. Activation of Akt can be regulated by a
number of different signals, including glutamate (52) or neurotrophic
(53,54) signals and Ca
2+ signalling (55). Activated Akt is in turn involved
in down-regulation of GSK3-b activity which is involved in regulation of a
number of transcription factors, including MEF2 (56) and CREB (57),
which is an orthologue of Drosophila Nej. Both CREB and MEF2 have
been demonstrated to play a role in the regulation of expression of the
nuclear receptor NUR77, an orthologue of Drosophila Hr38, in a calcium-
dependent manner (58). Activation of NUR77 can also be regulated directly
by Akt (59). The Akt/GSK3-b signalling pathway is therefore able to have
broad downstream transcriptional effects. A number of links between Akt
activity and expanded repeat-containing proteins themselves have also been
demonstrated. Akt phosphorylates HTT, ataxin-1 and the androgen receptor
(AR) (stars), altering their interactions with other proteins (60–62). Phos-
phorylation of ataxin 3 by GSK3-b (star) has also been recently demonstrated
to regulate nuclear entry and therefore may play a role in SCA3 (63).
Expression of expanded CUG repeats has also been demonstrated to alter acti-
vation of the Akt/Gsk3-b pathway in PC12 cells (64).
Figure 6. AlteringexpressionofGSK3-bcanmodifytheeffectofexpressionof
expandedrepeatRNAsintheDrosophilaeye.(A–C)Phenotypesresultingfrom
expression of translated CAG, CAA and CUG repeat expression, as shown in
Figure 2.( D) Expression of RNAi construct targeting Drosophila sgg does not
alter the exterior appearance of the eye. (E and F) Co-expression of an RNAi
construct targeting sgg with polyglutamine encoded by either CAG or CAA
doesnotdramaticallyaltertheexteriorappearanceoftheeye.(G)Co-expression
of the sgg RNAi with polyleucine results in eyes of wild-type appearance. (H)
Ectopic expression of Sgg in the eye results in a severe rough eye phenotype
with a dramatic reduction in the size of the eye and the amount of pigmentation.
(I and J) Co-expression of polyglutamine encoded by either a CAG or CAA
repeat with ectopically expressed Sgg results in an increase in the size of the
eye compared with ectopic expression of Sgg alone. There appears to be a
reductionintheamountofpigmentintheeyeandinmostcasestherearenecrotic
patches and nearly complete loss of the ommatidial array structure. (K) Ectopic
expression of Sgg in the eye of ﬂies co-expressing polyleucine is completely
lethal. (L–P) Expression of four insertions of any of the untranslated expanded
repeats alone does not result in a visible phenotype in the eye, as shown in
Figure 2.( Q) Driving expression of four insertions of the UAS portion of the
transgene without the remainder of the construct in ﬂies ectopically expressing
sgg in the eye results in a milder rough eye phenotype than expression of sgg
alone. (S) Co-expression of four transgene insertions of the rCAA construct
with the Sgg overexpression construct does not signiﬁcantly alter the organiz-
ation of the eye compared with co-expressing the UAS sites alone. (R and T)
Co-expression of the rCAG or rAUUCU repeat constructs with the Sgg overex-
pression construct results in eyes which are consistently rougher than those of
ﬂies co-expressing either rCAA or the UAS construct with Sgg. (U)
Co-expression of rCUG with the Sgg overexpression construct results in com-
plete lethality at 258C. At 238C, the few ﬂies which survive to eclosion have a
strong loss of pigment phenotype, with the loss of ommatidial structures and
the appearance of necrotic patches.
Human Molecular Genetics, 2011, Vol. 20, No. 14 2789expanded repeat sequences tested and Sgg in this model, the
strength of this interaction is affected by the sequence of the
repeat.
DISCUSSION
Identiﬁcation of the molecular pathway(s) from mutation to
clinical symptoms in the dominantly inherited neurodegenera-
tive diseases has proved extremely difﬁcult. A contributing
factor to this is that the sensitive cells of affected individuals
are lost in the course of the disease. Animal models therefore
afford the opportunity to access cells in which the pathogenic
pathways are active and also to explore alternative hypotheses
as to the nature of the pathogenic agent(s) responsible for these
diseases. RNA is such a potential pathogen in the dominantly
inherited expanded repeat neurodegenerative diseases. The use
of animal models such as Drosophila enables the identiﬁcation
of pathways through which such potential pathogens act and
the identiﬁcation of biomarkers of the responsible pathways.
These biomarkers can subsequently be tested in the respective
human diseases to validate the role of the pathway and its con-
tribution to the disease. Using this approach, we have mod-
elled repeat RNA pathology in Drosophila and have
identiﬁed common pathways perturbed by the expression of
expanded repeat RNAs.
Analyses of transcriptional changes in a number of models
of expanded repeat disease have previously been reported
(34–40). These studies have largely modelled toxicity of poly-
glutamine, which induces severe, early phenotypes in both
mouse and Drosophila models, and therefore transcriptional
changes are likely to partially reﬂect downstream effects of
cell death. More recently, evidence for a role of RNA-
mediated pathogenesis in the polyglutamine diseases has
been reported (18). Since expression of each of the repeat
sequences as untranslated RNA either in the Drosophila eye
or throughout the nervous system does not result in gross
developmental or degenerative phenotypes, this model can
be used to investigate markers of cellular dysfunction attribu-
table to these repeat sequence RNAs which precede cell death
and are therefore more likely to represent causative changes in
disease progression.
Given the ability of all of the disease-associated repeat
sequences to form hairpin secondary structures at the RNA
level and the phenotypic overlap seen in the expanded
repeat diseases, despite the presence of the repeat tracts
within unrelated genes, we predicted that there are likely to
be common, intrinsic, sequence-independent cellular effects
of expression of expanded repeat sequences. In support of
this prediction, pan-neuronal expression of rCAG, rCUG and
rAUUCU expanded repeat RNAs was found to elicit a
number of common transcriptional changes. Strikingly, a com-
parison of transcripts showing altered expression in ﬂies
expressing rAUUCU repeat RNA revealed a minimum of
40.7% and maximum of 71.4% overlap with genes altered in
ﬂies expressing either rCAG or rCUG repeats (Fig. 3E).
This result is strongly suggestive of common mechanisms of
toxicity of expanded repeat RNAs.
In the untranslated expanded repeat diseases where there is
no toxic peptide expressed, RNA-mediated pathogenesis is
presumably sufﬁcient to induce all of the cellular changes
leading to neurodegeneration and disease progression. This
Drosophila model of RNA repeat pathogenesis investigates
some components of pathogenesis in these diseases, but
there are also likely to be speciﬁc effects of expression of
the repeat-containing transcript in each disease which are
dependent on the context of the repeat tract. Nevertheless, at
least one candidate which showed a strong interaction with
context-independent repeat RNAs used in this study,
mod(mdg4), has been previously identiﬁed as transcriptionally
altered in another Drosophila model which used repeats within
the context of the SCA8 transcript (24).
In addition, changes identiﬁed in these microarray analyses
support a role for more generalized transcriptional dysregula-
tion in toxicity of expanded repeat RNAs. In particular, altered
transcript levels of histones (H3 and H1), histone acetylating
enzymes (msl-2 and Atac1), chromatin modiﬁers
(mod(mdg4)), a number of transcription factors (including
mef2, lola, cut, hr38, a member of the SP1/SP3-like transcrip-
tion factor family and a Drosophila orthologue of PAX5) and
transcriptional co-regulators (tna and med24) were detected in
ﬂies expressing more than one of the repeat sequences (Sup-
plementary Material, Tables S1 and S2). This is consistent
with observations in several models of polyglutamine patho-
genesis in which wide-spread transcriptional dysregulation
has been reported (35,40,41) and suggests that this sort of
effect may be an intrinsic property of expanded repeat
sequences.
Examination of common transcriptional changes detected in
this model also revealed changes to a number of other com-
ponents of the cell that have been previously implicated in
polyglutamine pathogenesis, including several cellular trans-
port and cytoskeletal components. For example, the actin-
binding proteins hu li tai shao, which is an orthologue of
mammalian Adducin 1, and cut up, a component of the
dynein complex, both showed altered expression in ﬂies
expressing more than one of the expanded repeat sequences
(Fig. 3F). Hu li tai shao has been previously demonstrated
to suppress a phenotype associated with expression of an
expanded N-terminal fragment of Huntingtin in the
Drosophila eye (29), while cut up and its human orthologue,
DYNLL1, showed altered expression in a comparison of
Drosophila and human cell culture models of polyglutamine
pathogenesis (37). We therefore predict that some of the
pathogenic pathways previously identiﬁed in models of
expanded repeat disease may be common to both polygluta-
mine and untranslated repeat diseases and therefore some of
these effects may be at least partially mediated through
RNA pathogenesis.
Recently published data (42) demonstrate that expanded
CAG repeat alleles are able to be translated internally in all
three reading frames, irrespective of whether or not they are
located in coding regions and without requiring an initiation
AUG, through a mechanism known as repeat-associated
non-ATG translation (RAN translation). It is thought that the
hairpin structure formed by the expanded repeat RNAs is
acting as an Internal Ribosome Entry Site (IRES). In our
model, expression of up to four transgene insertions of
untranslated CAG and CUG repeat sequences does not result
in a phenotype, while expression of a single polyglutamine
2790 Human Molecular Genetics, 2011, Vol. 20, No. 14or polyleucine-encoding transgene is sufﬁcient to induce a
visible phenotype in the Drosophila eye (Fig. 2; 8). Therefore,
RAN translation does not appear to play a major role in RNA
toxicity in this model. However, as a consequence of these
recent ﬁndings, homopolymeric amino acid sequences have
emerged as a potential mediator of repeat RNA toxicity in
the ‘untranslated’ repeat diseases.
Altered transcription of components of the Akt/GSK3-b
regulatory pathway was consistently observed in ﬂies expres-
sing rCAG, rCUG and rAUUCU repeat RNAs by microarray
analysis, suggesting that this is a key component of cellular
dysfunction in this Drosophila model of untranslated repeat
disease pathogenesis. While the ability of CUG repeat RNA
to disrupt Akt/GSK3-b signalling has been described, this is
the ﬁrst evidence that expression of other hairpin-forming
RNA species can also inﬂuence activity of this pathway.
The initial stimulus resulting in the disruption of Akt/
GSK3-b signalling in this model is unclear; however, there
is precedent for similar effects in fragile X syndrome where
increased levels of stimulation of the mGluR5 receptor have
been demonstrated to increase GSK3-b activity (43). A disrup-
tion to mGluR5 signalling has also been described in a pre-
symptomatic model of HD (44), and in other HD models
alterations to N-methyl-D-aspartate receptor (45), brain-
derived neurotrophic factor (46,47) and nerve growth factor
(48) signalling, all of which are associated with activation of
the Akt/GSK3-b pathway, have also been observed. Our
observations indicate that expression of expanded repeat
RNA is sufﬁcient to cause transcriptional changes to the
Akt/GSK3-b pathway, and therefore that the hairpin RNAs
expressed in the disease situation might also interact with
components of this pathway to disrupt normal signalling.
MATERIALS AND METHODS
Drosophila strains and husbandry
CAG and CUG repeats were generated by ligating together
shorter repeat oligonucleotides and expanded using polymerase
chain reaction (PCR)-based techniques as described previously
(8). The AUUCU repeat construct was generated from a PCR
productcontainingtheregioninintron9ofhumanataxin-10con-
tainingtheAUUCUrepeat,plus141 bpofsurroundingsequence
which was ampliﬁed from HeLa cell DNA. This repeat tract was
expanded from an original size of 13 repeats by a PCR-based
method, based on a previously outlined protocol (49).
Each repeat sequence was subcloned into the Drosophila
transformation vector pUAST, which had been modiﬁed to
contain the amino acid sequence surrounding the repeat,
including the MYC and FLAG epitope tags. For the untrans-
lated repeat constructs, a stop codon was inserted in front of
the repeat tract by PCR mutagenesis as described previously
(8). The length and integrity of repeat constructs were con-
ﬁrmed by DNA sequencing and then each construct was
microinjected into the w
1118 strain (Stock #3605) by standard
methods to obtain germline transformants. Multiple transgenic
lines were obtained for each construct, and the repeat length
from each line was conﬁrmed by PCR and sequencing.
The GMR-GAL4 (Stock #9146), elav
c155-GAL4 (Stock
#458) and P{GAL4-elav.L}2 (designated elavII) (Stock
#8765) strains used in this study were obtained from the
Bloomington Drosophila stock centre (Indiana University,
Indiana, PA, USA). GMR-GAL4 drives expression of UAS
constructs in all cells posterior of the morphogenetic furrow
in the developing eye. Both elav-GAL4 insertions drive
expression of UAS constructs throughout the central and per-
ipheral nervous system.
RNAi strains tested for genetic interaction with expanded
repeats were obtained from the Vienna Drosophila RNAi
centre (50). VDRC strains shown in ﬁgures are: Stock
#15550 (mef2), 52268 (mod(mdg4)) and 101538 (Sgg).
UAS-Sgg was obtained from the Bloomington Drosophila
stock centre (Stock #5361). All Drosophila stocks were main-
tained in vials containing Fortiﬁed (F1) medium and kept at
either 18 or 258C. The F1 medium was composed of 1%
agar, 18.75% compressed yeast, 10% polenta, 10% treacle,
1.5% acid mix and 2.5% tegosept. Crosses were performed
at 258C unless otherwise indicated.
RNA extraction and puriﬁcation
Approximately 100 male Drosophila heads from newly
eclosed ﬂies were collected and snap frozen for each genotype,
before homogenization in Trizol (Invitrogen). Total RNA was
extracted using chloroform and precipitated with isopropanol,
and then further puriﬁed using the RNeasy mini kit (Qiagen).
RNA to be used for microarrays was precipitated in sodium
acetate and ethanol and shipped under ethanol on ice.
Quantitative real-time PCR
One microgram of total RNA per sample was treated with
DNAse I (Invitrogen) and reverse-transcribed with
oligo(dT)18 and SuperScript III (Invitrogen). Quantitative
real-time PCR was performed in a LightCycler (Roche
Molecular Biochemicals) using Power SYBR green mix
(Applied Biosystems) and either GAL4-speciﬁc primers
(forward: 5′-CACTGACCCCGTCTGCTTTG-3′, and reverse:
5′-GGTTCGGACCGTTGCTACTG-3′) or primers speciﬁc
for the repeat-containing transcript. The transgene expression
level was quantiﬁed using the DCt method for relative quanti-
tation and expressed relative to the level of GAL4 transcript
for each line.
Microarrays
Total RNA was processed using the One-Cycle Target Label-
ling and Control Reagents Kit, as per manufacturer’s instruc-
tions (Affymetrix Inc.). Brieﬂy, 2 mg of total RNA was
converted to cDNA (Superscript II, Invitrogen) and an over-
night in vitro transcription reaction performed to generate a
pool of cRNA carrying a biotin tag (MEGAscript T7 Kit,
Ambion, Inc). The Drosophila Genome 2.0 Array was hybri-
dized for 16 h and washed/stained on a FS 450 Fluidics
Station using the Midi euk2 v3 script. Data were acquired
on a 7G GeneChip Scanner 3000 and data extraction per-
formed in GCOS v1.2. Candidates were selected from the
pool of transcripts which showed a ‘present’ call in either all
independent lines for a particular repeat sequence, or in all
samples for the elav-GAL4/+ control in that experiment.
Human Molecular Genetics, 2011, Vol. 20, No. 14 2791Where possible, two-tailed Student’s t-tests were performed
on raw values to identify signiﬁcantly altered transcripts
(P-value , 0.05). The microarray data have been deposited
on the NCBI database (GEO accession number GSE27178).
Microscopy
Image preparation was performed using Adobe Photoshop 6.0.
Light photos were taken with an Olympus SZX7 dissection
microscope ﬁtted with an SZX-AS aperture. Images were cap-
tured with a Colorview IIIu camera and AnalysisRuler image
acquisition software. In all cases, anterior is to the left. Flies
were photographed at 24–48 h post-eclosion.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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